Eli Lilly and Co said its board  decided to sell Elizabeth Arden Inc, a wholly owned subsidiary  that manufactures and markets cosmetics and fine fragrance  products.
It said the business, which had sales of 67 mln dlrs when  it was acquired in 1971, had sales last year of 398 mln dlrs,  up 12 pct from 1985.
In a statement, Lilly Chairman Richard Wood said "This  strategic decision was reached on the basis of our belief that  in the future the corporation's resources, including its  research activities, should be focused on its other business  which have a high technology, life sciences orientation."